Evaluating treatments of borderline personality disorder

Robert S Biskin and Joel Paris

Borderline personality disorder (BPD) is a complex psychiatric disorder that has a history of being difficult to treat. The past two decades have seen remarkable changes in the field with an increasing number of specialized psychotherapies and medications tested. Many of these studies have limitations that are specific to the treatment of BPD, including complexities regarding diagnosis, comorbidities, choice of outcome measures and choice of comparison treatment. Evaluating these studies, particularly in the context of changing diagnostic systems, is highly important. The future of BPD treatment, which can include earlier diagnosis and intervention, as well as integration of different psychotherapies, rests on a solid

understanding of the evidence that exists today.